Emergent BioSolutions Appoints Nina DeLorenzo as Senior Vice President of Global Public AffairsGlobeNewsWire • 04/06/20
Emergent BioSolutions gets $14.5M in federal funding to expedite COVID-19 plasma therapy developmentTechCrunch • 04/03/20
Emergent BioSolutions Partners with U.S. Government for Comprehensive Response to Expedite Development of Plasma-Derived Therapy for COVID-19GlobeNewsWire • 04/02/20
Why Is Emergent Biosolutions (EBS) Down 23.6% Since Last Earnings Report?Zacks Investment Research • 03/21/20
EMERGENT BIOSOLUTIONS SIGNS DEVELOPMENT AND MANUFACTURING AGREEMENT WITH VAXART FOR THEIR EXPERIMENTAL ORAL VACCINE CANDIDATE FOR CORONAVIRUS DISEASEGlobeNewsWire • 03/18/20
Emergent BioSolutions Initiates Development of Plasma-Derived Product Candidates for the Treatment and Prevention of Coronavirus DiseaseGlobeNewsWire • 03/11/20
Teladoc, Ping Identity, Emergent Biosolutions: Portfolio Manager Shares Stock Picks After Monday's CarnageBenzinga • 03/10/20
Emergent BioSolutions Signs Development and Manufacturing Agreement With Novavax for Experimental Vaccine Candidate for Coronavirus DiseaseGlobeNewsWire • 03/10/20
Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/21/20
Emergent BioSolutions Receives Positive CHMP Opinion for Vaxchora; Anticipates Near-Term Approval by European Medicines AgencyGlobeNewsWire • 01/31/20